Elanco Animal Health (ELAN) Total Debt (2018 - 2026)
Elanco Animal Health's (ELAN) quarterly Total Debt came in at $4.0 billion in Q1 2026, down 9.19% year-on-year from $4.4 billion in Q1 2025, and down 0.65% quarter-over-quarter from $4.0 billion in Q4 2025.
Elanco Animal Health (ELAN) Total Debt (2018 - 2026) Analysis & Trends
Elanco Animal Health has disclosed Total Debt across 9 years of filings, most recently posting $4.0 billion for Q1 2026.
- Total Debt for Q1 2026 came in at $4.0 billion, down 9.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.0 billion (down 9.19% YoY), and the FY2025 annual result was $4.0 billion, down 7.04% from the prior year.
- Total Debt came in at $4.0 billion for Q1 2026 at Elanco Animal Health, down from $4.0 billion in the prior quarter.
- In the past five years, Total Debt ranged from a high of $6.1 billion in Q1 2022 to a low of $4.0 billion in Q1 2026.
- The 5-year median for Total Debt is $5.8 billion (2024), against an average of $5.2 billion.
- Across the five-year window, Total Debt advanced 0.14% in 2023 and retreated 26.27% in 2024, its largest moves.
- Elanco Animal Health's Total Debt stood at $5.8 billion in 2022, then slipped by 1.06% to $5.8 billion in 2023, then fell by 25.16% to $4.3 billion in 2024, then fell by 7.04% to $4.0 billion in 2025, then fell by 0.65% to $4.0 billion in 2026.
- The last three Total Debt figures came in at $4.0 billion (Q1 2026), $4.0 billion (Q4 2025), and $4.0 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 16.63 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 3.53 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 3.99 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.51 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 570.41 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.99 Bn |
| Dec 31, 2025 | 4.02 Bn |
| Sep 30, 2025 | 4.02 Bn |
| Jun 30, 2025 | 4.21 Bn |
| Mar 31, 2025 | 4.40 Bn |
| Dec 31, 2024 | 4.32 Bn |
| Sep 30, 2024 | 4.36 Bn |
| Jun 30, 2024 | 5.68 Bn |
| Mar 31, 2024 | 5.77 Bn |
| Dec 31, 2023 | 5.77 Bn |
| Sep 30, 2023 | 5.91 Bn |
| Jun 30, 2023 | 6.06 Bn |
| Mar 31, 2023 | 6.02 Bn |
| Dec 31, 2022 | 5.84 Bn |
| Sep 30, 2022 | 5.90 Bn |
| Jun 30, 2022 | 6.06 Bn |
| Mar 31, 2022 | 6.13 Bn |
| Dec 31, 2021 | 6.32 Bn |
| Sep 30, 2021 | 6.33 Bn |
| Jun 30, 2021 | 6.10 Bn |